HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Avascular necrosis of the jaw bone after bisphosphonate therapy].

Abstract
Bisphosphonates have an antiosteolytic effect by the inhibition of osteoclastic action. Although the exact mode of action is not completely understood, major progress on both the cellular and molecular levels has been made in recent years. Bisphosphonates alleviate pain and reduce complications, such as pathologic fractures, or hypercalcemia. Dental and periodontal research has shown great interest in clinical applications of bisphosphonates' antiosteolytic and antiosteoclastic traits, since they can be applied to counteract bone loss in chronic periodontitis. Investigations have associated avascular necrosis events in the jawbones with bisphosphonate therapy. Maxillary and mandibular osteonecrotic foci accompanied by pain, inconvenience and purulent exudates were incidentally found in patients who were taking pamidronate (Aredia), zolendronate (Zometa) and even alendronate (Fosalan). Our institutional database search over the past year yielded ten patients who were admitted to the Oral and Maxillofacial Surgery Unit at the Tel Aviv Sourasky Medical Center, due to an osteonecrotic bone lesion coupled with a prior history of bisphosphonate therapy. All these patients also had a recent dental extraction. They were all treated according to the osteomyelitis protocol, and their response to therapy varied from several weeks to many months, with some cases requiring repeat surgical intervention (curettage or sequestrectomy). This article strives to alert on the possible linkage between drug therapy using bisphosphonates and the serious event of avascular jawbone necrosis. The important role of the oral surgeon in following up on this group of patients should not be underestimated.
AuthorsBinyamin Shlomi, Yaacov Levy, Shlomi Kleinman, Hadar Better, Adi Kahn, Alexander Shtabsky, Gavriel Chaushu
JournalHarefuah (Harefuah) Vol. 144 Issue 8 Pg. 536-9, 600, 599 (Aug 2005) ISSN: 0017-7768 [Print] Israel
PMID16146148 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Analgesics
  • Diphosphonates
Topics
  • Adult
  • Aged
  • Analgesics (adverse effects)
  • Diphosphonates (adverse effects)
  • Female
  • Humans
  • Jaw (drug effects, pathology)
  • Male
  • Mandible (drug effects, pathology)
  • Maxilla (drug effects, pathology)
  • Middle Aged
  • Necrosis
  • Osteonecrosis (chemically induced)
  • Pain
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: